Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001756770-25-000030
Filing Date
2025-08-07
Accepted
2025-08-06 20:43:38
Documents
7
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K q2256-kcover.htm 6-K 15266
2 EX-99.1 q225-exx992xfsandmda.htm EX-99.1 2638824
3 EX-99.2 q225ceocertification.htm EX-99.2 12166
4 EX-99.3 q225cfocertification.htm EX-99.3 11794
5 EX-99.4 q225earningsrelease.htm EX-99.4 289828
6 GRAPHIC curlf-20221231xex99d2001a.jpg GRAPHIC 13984
7 GRAPHIC image_0.jpg GRAPHIC 8736
  Complete submission text file 0001756770-25-000030.txt   3000590
Mailing Address 420 LEXINGTON AVENUE NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE NEW YORK NY 10170 781-451-0117
Curaleaf Holdings, Inc. (Filer) CIK: 0001756770 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)